|
1
|
Escobar Y, Cajaraville G, Virizuela JA,
Álvarez R, Muñoz A, Olariaga O, Tamés MJ, Muros B, Lecumberri MJ,
Feliu J, et al: Incidence of chemotherapy-induced nausea and
vomiting with moderately emetogenic chemotherapy: ADVICE (Actual
data of vomiting incidence by chemotherapy evaluation) study.
Support Care Cancer. 23:2833–2840. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hayashi T, Shimokawa M, Matsuo K, Iihara
H, Kawada K, Nakano T and Egawa T: Chemotherapy-induced nausea and
vomiting (CINV) with carboplatin plus pemetrexed or carboplatin
plus paclitaxel in patients with lung cancer: A propensity
score-matched analysis. BMC Cancer. 21:742021. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gupta K, Walton R and Kataria SP:
Chemotherapy-induced nausea and vomiting: Pathogenesis,
recommendations, and new trends. Cancer Treat Res Commun.
26:1002782021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hata A, Okamoto I, Inui N, Okada M, Morise
M, Akiyoshi K, Takeda M, Watanabe Y, Sugawara S, Shinagawa N, et
al: Randomized, double-blind, phase III study of fosnetupitant
versus fosaprepitant for prevention of highly emetogenic
chemotherapy-induced nausea and vomiting: CONSOLE. J Clin Oncol.
40:180–188. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Herrstedt J, Lindberg S and Petersen PC:
Prevention of chemotherapy-induced nausea and vomiting in the older
patient: Optimizing outcomes. Drugs Aging. 39:1–21. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Samami E, Shahhosseini Z, Hamzehgardeshi Z
and Elyasi F: Psychological interventions in chemotherapy-induced
nausea and vomiting in women with breast cancer: A systematic
review. Iran J Med Sci. 47:95–106. 2022.PubMed/NCBI
|
|
7
|
Yoshikawa K, Higashijima J, Okitsu H,
Miyake H, Yagi T, Miura M, Bando Y, Ando T, Hotchi M, Ishikawa M,
et al: Effects of chemotherapy on quality of life and night-time
sleep of colon cancer patients. J Med Invest. 67:338–342. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li W, Zhou Q, Liu W, Xu C, Tang ZR, Dong
S, Wang H, Li W, Zhang K, Li R, et al: A machine learning-based
predictive model for predicting lymph node metastasis in patients
with Ewing's sarcoma. Front Med (Lausanne). 9:8321082022.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dong S, Yang H, Tang ZR, Ke Y, Wang H, Li
W and Tian K: Development and validation of a predictive model to
evaluate the risk of bone metastasis in kidney cancer. Front Oncol.
11:7319052021. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rizzo A, Mollica V, Tateo V, Tassinari E,
Marchetti A, Rosellini M, De Luca R, Santoni M and Massari F:
Hypertransaminasemia in cancer patients receiving immunotherapy and
immune-based combinations: The MOUSEION-05 study. Cancer Immunol
Immunother. 72:1381–1394. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rizzo A, Santoni M, Mollica V, Logullo F,
Rosellini M, Marchetti A, Faloppi L, Battelli N and Massari F:
Peripheral neuropathy and headache in cancer patients treated with
immunotherapy and immuno-oncology combinations: The MOUSEION-02
study. Expert Opin Drug Metab Toxicol. 17:1455–1466. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rizzo A: Immune checkpoint inhibitors and
mismatch repair status in advanced endometrial cancer: Elective
affinities. J Clin Med. 11:39122022. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guven DC, Erul E, Kaygusuz Y, Akagunduz B,
Kilickap S, De Luca R and Rizzo A: Immune checkpoint
inhibitor-related hearing loss: A systematic review and analysis of
individual patient data. Support Care Cancer. 31:6242023.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sahin TK, Rizzo A, Aksoy S and Guven DC:
Prognostic significance of the Royal Marsden Hospital (RMH) score
in patients with cancer: A systematic review and meta-analysis.
Cancers (Basel). 16:18352024. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Oken MM, Creech RH, Tormey DC, Horton J,
Davis TE, McFadden ET and Carbone PP: Toxicity and response
criteria of the Eastern Cooperative Oncology Group. Am J Clin
Oncol. 5:649–655. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zung WW: A rating instrument for anxiety
disorders. Psychosomatics. 12:371–379. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Buysse DJ, Reynolds CF III, Monk TH,
Berman SR and Kupfer DJ: The pittsburgh sleep quality index: A new
instrument for psychiatric practice and research. Psychiatry Res.
28:193–213. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zung WW: A self-rating depression scale.
Arch Gen Psychiatry. 12:63–70. 1965. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tan JY, Suen LK and Molassiotis A:
Psychometric assessment of the Chinese version of the MASCC
antiemesis tool (MAT) for measuring chemotherapy-induced nausea and
vomiting. Support Care Cancer. 24:3729–3737. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Huang SH and O'Sullivan B: Overview of the
8th edition TNM classification for head and neck cancer. Curr Treat
Options Oncol. 18:402017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hohenegger M: Pharmacokinetic
considerations in geriatric cancer patients. Memo. 14:11–14. 2021.
View Article : Google Scholar
|
|
22
|
Williams GR, Outlaw D, Harvey RD, Lichtman
SM, Zamboni WC and Giri S: Chemotherapy dosing in older adults with
cancer: One size does NOT fit all. J Geriatr Oncol. 14:1013632023.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mosa ASM, Hossain AM, Lavoie BJ and Yoo I:
Patient-related risk factors for chemotherapy-induced nausea and
vomiting: A systematic review. Front Pharmacol. 11:3292020.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schmitz NCM, van der Werf YD and
Lammers-van der Holst HM: The importance of sleep and circadian
rhythms for vaccination success and susceptibility to viral
infections. Clocks Sleep. 4:66–79. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Quesnel C, Savard J, Simard S, Ivers H and
Morin CM: Efficacy of cognitive-behavioral therapy for insomnia in
women treated for nonmetastatic breast cancer. J Consult Clin
Psychol. 71:189–200. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Berger AM, Kuhn BR, Farr LA, Von Essen SG,
Chamberlain J, Lynch JC and Agrawal S: One-year outcomes of a
behavioral therapy intervention trial on sleep quality and
cancer-related fatigue. J Clin Oncol. 27:6033–6040. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bai L, Ni L, Lu J, Zhang YY, Yin Y, Zhang
W and Duan X: Relationship between nausea and vomiting and physical
activity in patients with lung cancer undergoing first
chemotherapy. Front Oncol. 14:13966372024. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gonzalez-Ling A, Galindo Vázquez O,
Espinoza Bello M, Robles R, Rascón-Gasca ML, Lara-Mejía L, Heredia
D and Arrieta O: Quality of life, anxiety, depression, and distress
in patients with advanced and metastatic lung cancer. Palliat
Support Care. 21:608–615. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lin LY, Lin LH, Tzeng GL, Huang YH, Tai
JF, Chen YL, Wu CJ, Chen PH, Lin PC and Hung PL: Effects of
mindfulness-based therapy for cancer patients: A systematic review
and meta-analysis. J Clin Psychol Med Settings. 29:432–445. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kang C: Approach the prevention of
chemotherapy-induced nausea and vomiting in older patients with
care. Drugs & Therapy Perspectives. 38:483–488. 2022.
View Article : Google Scholar
|
|
31
|
Affronti ML, Lee J, Molassiotis A, Johnson
L, Tinianov S, Clark-Snow R and Scotte F: MASCC 2023
patient-centered antiemetic guidelines and education statements: An
evidence-based and consensus resource for patients. Support Care
Cancer. 32:3352024. View Article : Google Scholar : PubMed/NCBI
|
